A short-acting GHRH agonist, a variant of CJC-1295 without the drug affinity complex modification.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 5 mg vial takes 0.5 mL of water for a clean 10 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration | 100 mcg draws to |
|---|---|---|---|
| 5 mg | 0.5 mL | 10 mg/mL | 1 units |
| 10 mg | 1 mL | 10 mg/mL | 1 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 100 mcg. At 10 mg/mL, that draws to 1 units on a U-100 insulin syringe.
GHRH receptor agonist that stimulates pituitary growth hormone release in short, natural bursts.
CJC-1295 No DAC is commonly taken in the evening.
Add 0.5 mL of bacteriostatic water to a 5 mg CJC-1295 No DAC vial for a 10 mg/mL solution.
A common CJC-1295 No DAC starting dose is 100 mcg, which at 10 mg/mL draws to 1 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the CJC-1295 No DAC vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.